Inicio › Cáncer de vejiga › Texas › Houston
Ensayos clínicos de Cáncer de vejiga en Houston, TX
31 estudios para Cáncer de vejiga buscan participantes en centros de Houston y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
ReclutandoFase 1
- University of Texas MD Anderson Cancer Center, Houston
- The University of Texas, MD Anderson Cancer Center - West Houston, Houston
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
ReclutandoFase 1
- University of Texas MD Anderson Cancer Center, Houston
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- UT MD Anderson Cancer Center, Houston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
ReclutandoFase 2
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
ReclutandoFase 1
- MD Anderson Cancer Center, Houston
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
ReclutandoFase 2
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
A Study of MGC026 in Participants With Advanced Solid Tumors
ReclutandoFase 1
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 2
- The University of Texas MD Anderson Cancer Center, Houston
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
ReclutandoFase 3
- UT MD Anderson Cancer Center, Houston
- UT MD Anderson - West Houston, Houston
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
ReclutandoFase 1/2
- Texas Oncology - Gulf Coast, Houston
- Texas Oncology - Gulf Coast, Houston
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
ReclutandoFase 3
- University of Texas MD Anderson Cancer Center, Houston
Measuring Surgical Recovery After Radical Cystectomy
ReclutandoEstudio observacional
- University of Texas MD Anderson Cancer Center, Houston
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
ReclutandoFase 3
- Houston Metro Urology, Houston
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
ReclutandoFase 1
- MD Anderson, Houston
- NEXT Oncology Houston, Houston
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
ReclutandoFase 1/2
- MD Anderson Cancer Center, Houston
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
ReclutandoFase 1
- MD Anderson Cancer Center, Houston
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
ReclutandoFase 2
- Houston Methodist, Houston
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
ReclutandoFase 2
- Houston Metro Urology, Houston
- Houston Methodist Hospital, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- The University of Texas, MD Anderson Cancer Center, Houston
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
ReclutandoFase 1/2
- Houston Metro Urology, Houston
- Houston Methodist Hospital - Department of Urology, Houston
- University of Texas - MD Anderson Cancer Center, Houston
IDOV-Immune for Advanced Solid Tumors
ReclutandoFase 1
- MD Anderson Cancer Center, Houston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
ReclutandoFase 2
- University of Texas MD Anderson Cancer Center, Houston
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
ReclutandoFase 2
- The University of Texas MD Anderson Cancer Center, Houston
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
ReclutandoFase 1
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
ReclutandoFase 1
- Oncology Consultants, PA, Houston
- Oncology Consultants, PA., Houston
- The University of Texas M.D. Anderson Cancer Center, Houston
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
ReclutandoFase 2
- Houston Methodist Neal Cancer Center, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
ReclutandoEstudio observacional
- Md Anderson Cancer Center, Houston
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
ReclutandoFase 1
- MD Anderson Cancer Center, Houston
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
ReclutandoFase 1
- Baylor St. Luke's Medical Center, Houston
Blue Light Cystoscopy With Cysview® Registry
ReclutandoEstudio observacional
- Michael E. DeBakey VA Medical Center, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Houston
Más información sobre Cáncer de vejiga en MedlinePlus
Ensayos de Cáncer de vejiga en otras ciudades
- New York City, NY36 estudios
- Nashville, TN31 estudios
- Dallas, TX27 estudios
- Boston, MA26 estudios
- Washington, DC26 estudios
- Los Angeles, CA25 estudios
- Baltimore, MD24 estudios
- Philadelphia, PA23 estudios
- Edison, NJ23 estudios
- St. Louis, MO22 estudios
- Chicago, IL21 estudios
- Seattle, WA21 estudios
Otros estudios en Houston
- Cáncer de pulmón de células no pequeñas143 estudios
- Cáncer de seno126 estudios
- Cáncer (todos los tipos)124 estudios
- Cáncer del colon y del recto101 estudios
- Cáncer metastásico100 estudios
- Cáncer de ovario90 estudios
- Leucemia mielógena aguda88 estudios
- Cáncer de pulmón78 estudios
- Cáncer de próstata73 estudios
- Cáncer de endometrio69 estudios
- Melanoma61 estudios
- Cáncer de páncreas59 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.